- Home
- Products
Poteligeo (Mogamulizumab-kpkc)
Poteligeo (Mogamulizumab-kpkc)
- Medicine Name: Poteligeo
- Generic Name: Mogamulizumab-kpkc
- Dosage Form & Strength: Injection – 20 mg/5 mL (4 mg/mL) in single-dose vial
- Manufactured By: Kyowa Kirin, Inc
Poteligeo is a CCR4-directed monoclonal antibody used for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome—both rare forms of cutaneous T-cell lymphoma (CTCL)—after at least one prior systemic therapy.
Recommended Dosage:
- 1 mg/kg IV infusion over at least 60 minutes
- Administer on Days 1, 8, 15, and 22 of the first 28-day cycle, then on Days 1 and 15 of subsequent cycles
- Premedication with acetaminophen and diphenhydramine is advised for the first infusion
- Resume schedule as soon as possible if a dose is missed
Severe Skin Reactions: Includes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN); discontinue immediately if suspected.
Infusion Reactions: May occur, especially during the first dose. Monitor and premedicate patients accordingly.
Serious Infections: Monitor closely and treat promptly for pneumonia, sepsis, or skin infections.
Immune-Mediated Reactions: May include autoimmune complications; interrupt or stop as clinically necessary.
Post-Transplant Risk: Increased risk of severe GVHD and transplant-related mortality in HSCT recipients.
Pregnancy & Lactation: Not recommended; contraception advised during and for 3 months post-treatment.
Required for Import:
- Prescription from a licensed doctor
- Diagnostic reports
- Government-issued ID proof
Availability:
Poteligeo is a prescription-only cancer medication available for import through the Named Patient Program. Global Rare Meds supports access across India including Mumbai, Delhi, Bengaluru, Chennai, Pune, and more.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds sources Poteligeo from authorized global suppliers and delivers it to Indian patients through our licensed fulfillment center in Ambernath, Thane District. All medications are pharmacist-verified and securely shipped.
Q: What is the generic name of Poteligeo®?
A: Mogamulizumab-kpkc
Q: Who manufactures Poteligeo®?
A: Kyowa Kirin, Inc.
Q: What is Poteligeo® approved for?
A: FDA-approved for relapsed/refractory mycosis fungoides or Sézary syndrome (2018)
Q: How is Poteligeo® supplied?
A: 20 mg/5 mL (4 mg/mL) injection in a single-dose vial
Q: Common side effects?
A: Rash, fatigue, diarrhea, musculoskeletal pain, respiratory infections, infusion-related reactions
Q: Storage conditions?
A: Store refrigerated at 2°C–8°C; do not freeze or shake. Protect from light.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
